--- title: Advanced Drug Formulation Development Services | Leukocare description: Partner with Leukocare to solve complex formulation challenges through data driven stability optimization, protein analytics, and expert development support. Submit your request and receive tailored scientific guidance. image: https://insights.leukocare.com/hubfs/ChatGPT%20Image%20Mar%2030%2c%202026%2c%2003_19_19%20PM-1-1.png --- ![Leukocare Logo (1)](https://insights.leukocare.com/hs-fs/hubfs/Leukocare%20Logo%20(1).webp?width=300&height=80&name=Leukocare%20Logo%20(1).webp "Leukocare Logo (1)") [Get Expert Feedback](https://insights.leukocare.com#speak-with-expert) Drug Product Formulation For Liquids and Lyophilized Products # Solve formulation challenges in Your Biologic Drug Development Overcome stability and aggregation challenges with data-driven formulation strategies [Get Expert Feedback](https://insights.leukocare.com#speak-with-expert) 20+ Years experience 400+ Successful projects 98% Client satisfaction Drug Product Formulation For Liquids and Lyophilized Products # Solve formulation challenges in Your Biologic Drug Development Overcome stability and aggregation challenges with data-driven formulation strategies [Get Expert Feedback](https://insights.leukocare.com#speak-with-expert) 20+ Years experience 400+ Successful projects 98% Client satisfaction Common challenges ## Struggling with Formulation Challenges? ![Stability-3](https://insights.leukocare.com/hs-fs/hubfs/Stability-3.png?width=73&height=73&name=Stability-3.png) Poor Stability Poor stability can compromise product quality and shelf life, putting development timelines and regulatory success at risk.    ![Insufficient Data-2](https://insights.leukocare.com/hs-fs/hubfs/Insufficient%20Data-2.png?width=57&height=57&name=Insufficient%20Data-2.png)   Insufficient Data Insufficient data makes it difficult to make confident decisions, often leading to delays and repeated experimentation.    ![Complex Requirements-2](https://insights.leukocare.com/hs-fs/hubfs/Complex%20Requirements-2.png?width=73&height=73&name=Complex%20Requirements-2.png) Complex Requirements Next-generation modalities and advanced TPPs create complexity where standard CDMO approaches fall short - requiring data-driven strategies for clear results.  Success story ## How We Transformed a Biologic Product Challenge Unstable formulation, limited shelf life at 2–8 °C   Our solution Data-driven formulation optimization strategy   The result Commercially viable product profile achieved   Outcome Shelf life extension achieved   +20 months   From unstable to commercially viable — enabling regulatory submission and market readiness. Challenge Unstable formulation, limited shelf life at 2–8 °C   Our solution Data-driven formulation optimization strategy   The result Commercially viable product profile achieved   Outcome Shelf life extension achieved +20 months From unstable to commercially viable — enabling regulatory submission and market readiness. Why Leukocare ## Trusted Formulation Expertise for Biologics & ATMPs 20+ Years of experience Supporting biologics formulation programs since 2002, across various modalities. 400+ Successful projects A deep track record across IND-ready, optimization, and stability programs. 98% Client satisfaction Clients who work with us return and refer others in their network.   State-of-the-art labs Advanced analytical and formulation infrastructure built for complex biologics.   " Our company had to deal with an unstable protein formulation, and Leukocare supported us with multiple rounds of formulation screening to find an improved formulation candidate. We appreciate the broad analytical capabilities, clear communication and timely delivery of results in clear reports.   ![Merus Logo](https://insights.leukocare.com/hs-fs/hubfs/Stability-1.png?width=88&height=88&name=Stability-1.png)   Merus N.V. Success story ## From Stability Challenge to Commercially Viable Formulation A biologic candidate with limited stability at 2–8°C required a more robust formulation strategy to support development goals. Using Leukocare's data-driven approach, the program moved toward a commercially viable product profile with improved stability potential. Challenge - Unstable Formulation at 2–8° - Significant Aggregation Risk Approach - Data-driven formulation optimization - Targeted stability strategy based on molecular insights - Systematic identification of critical stability drivers Outcome - +20 month shelf life extension - Reduced aggregation risk - Improved stability under real storage conditions   Result Shelf life extended by over 20 months — enabling regulatory submission and market readiness. Success story ## From Stability Challenge to Commercially Viable Formulation A biologic candidate with limited stability at 2–8°C required a more robust formulation strategy. Using Leukocare's data-driven approach, the program moved toward a commercially viable product profile. Challenge - Unstable Formulation at 2–8° - Significant Aggregation Risk   Approach - Data-driven formulation optimization - Targeted stability strategy based on molecular insights - Systematic identification of critical stability drivers   Outcome - +20 month shelf life extension - Reduced aggregation risk - Improved stability under real storage conditions   Shelf life extended by over 20 months — enabling regulatory submission and market readiness. Take the next step ## Ready to Optimize Your Drug Formulation? Get in touch with our formulation experts today. We'll review your challenge and respond shortly. [Get Expert Feedback](https://insights.leukocare.com#speak-with-expert)   ![Antibody structure](https://insights.leukocare.com/hs-fs/hubfs/Bild.png?width=360&height=300&name=Bild.png) " Working with Leukocare has been an exceptional experience. Their flexibility responding to our changing priorities and timelines has been instrumental in meeting our program goals. They truly operate as an extension of our internal team — collaborative, responsive, and fully aligned with our program objectives. What stands out is their scientific approach which revolves around thoughtful experimental design and the collection of robust data. Leukocare consistently delivered high-quality data and important insights that supported critical decision-making. Their combination of speed, scientific excellence, and teamwork makes them a trusted and valued partner on our development journey.   ![Elion Therapeutics Inc.-1](https://insights.leukocare.com/hs-fs/hubfs/Elion%20Therapeutics%20Inc.-1.png?width=88&height=88&name=Elion%20Therapeutics%20Inc.-1.png)   Elion Therapeutics Inc. ![](https://insights.leukocare.com/hs-fs/hubfs/Logo_Leukocare+Claim_100mm_cmyk-1.jpg?width=563&height=152&name=Logo_Leukocare+Claim_100mm_cmyk-1.jpg) GDPR compliant   Data secure   No spam, ever Impressum [Privacy Policy](https://www.leukocare.com/privacy-policy) © 2026 Leukocare AG